|
FLVCR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.378000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.143800E-02 |
| Normal-vs-Stage2 |
2.350600E-01 |
| Normal-vs-Stage3 |
2.383000E-01 |
| Normal-vs-Stage4 |
5.930800E-01 |
| Stage1-vs-Stage2 |
9.925400E-01 |
| Stage1-vs-Stage3 |
8.151800E-02 |
| Stage1-vs-Stage4 |
3.676000E-01 |
| Stage2-vs-Stage3 |
1.004250E-01 |
| Stage2-vs-Stage4 |
3.806800E-01 |
| Stage3-vs-Stage4 |
8.421000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.222600E-01 |
| Normal-vs-AfricanAmerican |
8.857700E-02 |
| Normal-vs-Asian |
5.793000E-01 |
| Caucasian-vs-AfricanAmerican |
2.193600E-01 |
| Caucasian-vs-Asian |
5.439800E-01 |
| AfricanAmerican-vs-Asian |
4.716600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.745700E-02 |
| Normal-vs-Female |
5.513700E-02 |
| Male-vs-Female |
9.623000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.590200E-01 |
| Normal-vs-Extreme_Weight |
9.576800E-04 |
| Normal-vs-Obese |
9.633200E-01 |
| Normal-vs-Extreme_Obese |
7.456800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.122400E-02 |
| Normal_Weight-vs-Obese |
6.579400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.665400E-01 |
| Extreme_Weight-vs-Obese |
7.176500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.108800E-01 |
| Obese-vs-Extreme_Obese |
7.755200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.783800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.447800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.615500E-02 |
| Normal-vs-Age(81-100Yrs) |
5.164800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.010000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.365410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.673900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.524400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.999500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.645600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.676050E-03 |
| Normal-VS-Type2 PRCC |
2.206600E-01 |
| Normal-VS-KIRP CIMP |
5.178000E-01 |
| Normal-VS-Unclassified PRCC |
5.015600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.061000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.685230E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.034450E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.701400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.870200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.720200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.705200E-01 |
| Normal-vs-N1 |
5.746500E-02 |
| Normal-vs-N2 |
8.615800E-01 |
| N0-vs-N1 |
3.691700E-02 |
| N0-vs-N2 |
6.678800E-01 |
| N1-vs-N2 |
4.890800E-01 |
|
|
